An Expert Report on Chlorhexidine (DB00878): A Comprehensive Analysis of its Pharmacology, Clinical Utility, and Safety Profile

Executive Summary and Overview

Chlorhexidine, identified by DrugBank ID DB00878, is a broad-spectrum bisbiguanide antiseptic that has served as a cornerstone of infection control in both medical and dental practice for over seven decades.[1] Developed in the early 1950s by Imperial Chemical Industries in the United Kingdom, its well-established efficacy and robust safety profile have secured its inclusion on the World Health Organization's List of Essential Medicines, a testament to its critical role in health systems worldwide.[1] Its primary utility is derived from its potent and persistent antimicrobial activity against a wide range of pathogens, including Gram-positive and Gram-negative bacteria, yeasts, and certain enveloped viruses.[1] This has led to its formulation in a vast array of products, from over-the-counter topical solutions for skin disinfection and surgical hand scrubs to prescription-only oral rinses for the management of gingivitis.[1]

Despite its long-standing use and its status as a "gold standard" antiseptic in many clinical scenarios, the contemporary understanding of chlorhexidine is increasingly complex and nuanced.[8] A pivotal development in its regulatory and safety history was the 2017 U.S. Food and Drug Administration (FDA) warning regarding rare but serious and potentially fatal anaphylactic reactions. This alert was prompted by a notable increase in the number of reported cases, highlighting a significant, albeit infrequent, risk associated with its widespread use.[10] This report provides a comprehensive, multi-faceted analysis of chlorhexidine, synthesizing extensive data on its chemical properties, synthesis, pharmacological mechanism, clinical applications, and available formulations. It critically examines the full spectrum of its safety profile, from common, manageable adverse effects like dental staining to the severe hypersensitivity reactions that now demand heightened clinical vigilance. Furthermore, this report explores the latest research into its broader ecological impact on the human microbiome, its potential to contribute to bacterial tolerance, and its evolving role in an era of evidence-based, procedure-specific antiseptic selection. The central theme that emerges is the inherent tension between chlorhexidine's established efficacy and a growing body of evidence that reveals significant risks and limitations, necessitating a paradigm shift from viewing it as a universally benign agent to one that requires careful, risk-stratified application.

Chemical Profile and Synthesis

A thorough understanding of chlorhexidine's clinical behavior begins with its fundamental chemistry. The molecule's structure, physicochemical properties, and synthesis pathway directly dictate its mechanism of action, formulation requirements, side effect profile, and potential for impurities.

Identification and Nomenclature

Chlorhexidine is a small molecule drug that is well-characterized across major chemical and pharmacological databases.[1]

• DrugBank ID: DB00878 [1]
• CAS Number: 55-56-1 (for the free base) [2]
• IUPAC Name: N′,N′′′′′−hexane−1,6−diylbis[N−(4−chlorophenyl)(imidodicarbonimidicdiamide)] [13]
• Synonyms: Reflecting its global use, chlorhexidine is known by numerous names, including 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide), Chlorhexidin, Clorhexidina, and the common abbreviations CHX and CHG.[1]

Molecular Structure and Physicochemical Properties

The molecular architecture of chlorhexidine is the key to its function. It is a symmetric, cationic bisbiguanide compound. Its structure is defined by two para-chlorophenyl rings and two biguanide groups, which are linked by a flexible central hexamethylene chain.[1] This configuration creates an amphipathic molecule, possessing both hydrophobic regions (the chlorophenyl rings) and strongly basic, hydrophilic regions (the biguanide groups). This dual nature is fundamental to its ability to interact with and disrupt microbial cell membranes.[17]

The chemical formula of the chlorhexidine base is C22​H30​Cl2​N10​.[1] Its average molecular weight is approximately 505.45 g/mol, with a monoisotopic mass of around 504.203 g/mol.[1]

The entire clinical profile of chlorhexidine can be seen as a cascade of consequences originating from its fundamental chemical properties. The molecule's large, symmetric structure renders the free base poorly soluble in water, a property that necessitates its formulation into various salts to be clinically useful in aqueous solutions like scrubs and mouthwashes. This same structure is strongly cationic at physiological pH, which is the primary driver of its antimicrobial mechanism—an electrostatic attraction to the negatively charged surfaces of bacteria. However, this cationic nature is also directly responsible for its most common side effect, extrinsic staining, as it binds to negatively charged chromogens in the diet and the oral pellicle. It also explains its chemical incompatibility with anionic compounds in toothpaste, a fact that dictates specific clinical usage guidelines. Finally, the industrial synthesis process itself introduces the risk of carrying over the reactant p-chloroaniline, a significant safety and regulatory concern. Thus, one cannot understand any single aspect of chlorhexidine—its efficacy, side effects, or formulation—in isolation from its core chemistry.

A summary of its key physicochemical properties is presented below.

Property	Value	Source(s)
Physical State	White to off-white/yellowish solid/powder	5
Melting Point	134-136 °C	5
Water Solubility	Very low; 0.08 g/100 mL (0.08%) at 20 °C	5
pKa (Strongest Basic)	~10.5−10.8	5
logP	~2.7−4.5	22

Commercially Relevant Salts

The very low water solubility of the chlorhexidine free base makes it impractical for most clinical applications. To overcome this, it is almost always formulated as a salt, which dramatically improves its solubility in water and alcohol.[2] The most common salt forms are:

• Chlorhexidine Gluconate (CHG): This is the most widely used and most water-soluble salt, formed by reacting the base with two equivalents of D-gluconic acid.[2] It is the active ingredient in the majority of antiseptic mouthwashes, oral gels, and aqueous skin preparation solutions.[17] Its CAS number is 18472-51-0, and its molecular formula and weight are C34​H54​Cl2​N10​O14​ and approximately 897.76 g/mol, respectively.[15]
• Chlorhexidine Diacetate: This salt is formed with acetic acid and is used in some topical and veterinary formulations.[15] Its CAS number is 56-95-1, and it has a molecular weight of approximately 625.55 g/mol.[15]
• Chlorhexidine Dihydrochloride: This salt, with CAS number 3697-42-5 and a molecular weight of approximately 578.37 g/mol (C22​H30​Cl2​N10​⋅2HCl), is another commercially available form.[27]

Synthesis Pathway and Impurities

The industrial-scale synthesis of chlorhexidine is typically a two-step process.[15] The first step involves the reaction of hexamethylenediamine dihydrochloride with sodium dicyanamide to produce the key intermediate, 1,6-hexamethylenebis(dicyandiamide).[5] In the second step, this intermediate is reacted with two equivalents of 4-chloroaniline hydrochloride under reflux conditions in a suitable solvent, such as ethanol or 2-ethoxyethanol, to yield the final chlorhexidine base.[15]

A critical aspect of the synthesis and stability of chlorhexidine is the presence of impurities. The most significant impurity is p-chloroaniline (PCA), which can be carried over from the synthesis reaction or formed via degradation of the chlorhexidine molecule, a process accelerated by high temperatures and low pH.[15] Because PCA is a known cytotoxic and potentially mutagenic substance, rigorous purification steps, such as recrystallization and solvent washing, are essential to reduce its concentration in the final active pharmaceutical ingredient (API) to acceptable levels.[15] Regulatory bodies like the FDA pay close attention to impurity profiles in chlorhexidine products, as excessive levels could compromise not only safety but also efficacy by reducing the concentration of the active ingredient.[32] Other degradation products and impurities, such as Chlorhexidine Impurity J, are also monitored according to pharmacopoeial standards.[33]

Pharmacology and Mechanism of Action

The clinical utility of chlorhexidine is rooted in its potent pharmacodynamic effects on microbial cells and its unique pharmacokinetic behavior, particularly its substantivity in the oral cavity.

Pharmacodynamics: Mechanism of Antimicrobial Action

Chlorhexidine is classified as a "membrane-active agent," exerting its antimicrobial effects through direct interaction with the microbial cell envelope.[17] The process is rapid, concentration-dependent, and can be described in distinct phases.

At physiological pH, chlorhexidine salts dissociate, releasing the bicationic (doubly positively charged) chlorhexidine molecule.[2] This initiates the first phase:

adsorption. The cationic molecule possesses a strong electrostatic affinity for negatively charged sites on the surface of microbial cells, such as the phosphate groups of teichoic acids in Gram-positive bacteria and lipopolysaccharides (LPS) in Gram-negative bacteria, as well as carboxyl groups on surface proteins.[2] This rapid binding displaces essential divalent cations like magnesium (

Mg2+) and calcium (Ca2+) that normally stabilize the membrane structure.[17]

The subsequent effects are dictated by the concentration of chlorhexidine:

• At low concentrations, the binding disrupts the osmotic equilibrium of the cell membrane, damaging its integrity and increasing its permeability. This leads to the leakage of low-molecular-weight intracellular components, most notably potassium ions (K+) and phosphorus. This disruption of the membrane's metabolic and osmoregulatory functions results in a bacteriostatic (growth-inhibiting) effect, which is considered reversible if the agent is removed.[2]
• At high concentrations, the interaction with the membrane is far more destructive. The extensive binding leads to a crystallization of the membrane, causing a catastrophic loss of its structural integrity. This results in the coagulation and precipitation of cytoplasmic contents, including proteins and nucleic acids, leading to irreversible cell damage and death. This is the bactericidal (cell-killing) mechanism of chlorhexidine.[2]

Antimicrobial Spectrum

Chlorhexidine exhibits a broad spectrum of activity, making it effective against a wide variety of microorganisms relevant to clinical infections.[1]

• Bacteria: It is highly effective against both Gram-positive and Gram-negative bacteria, including facultative anaerobes and aerobes.[2] Its potency is particularly high against Gram-positive organisms (e.g., Staphylococcus aureus), for which minimum inhibitory concentrations (MICs) can be as low as ≥1μg/L. Higher concentrations, typically in the range of 10 to over 73 µg/mL, are required for many Gram-negative bacteria and fungi, a difference attributed to the protective outer membrane of Gram-negative cells.[2]
• Fungi and Yeasts: It is effective against yeasts, such as Candida albicans.[1]
• Viruses: Its antiviral activity is limited primarily to enveloped viruses. It can disrupt the lipid envelopes of viruses such as Human Immunodeficiency Virus (HIV), Herpes simplex virus (HSV-1 and HSV-2), and Influenza A.[2] This property has led to recent investigations into its potential activity against other enveloped viruses like SARS-CoV-2.[34] It is notably ineffective against non-enveloped viruses, such as polioviruses and adenoviruses.[2]
• Limitations: A key limitation is its lack of sporicidal activity; it does not kill bacterial spores, although it can inhibit their germination and outgrowth.[2] It is also generally ineffective against mycobacteria, the causative agents of tuberculosis.[5]

Pharmacokinetics and Substantivity

When used as an oral rinse or topical agent, chlorhexidine exhibits minimal systemic absorption. If accidentally ingested, it is very poorly absorbed from the gastrointestinal tract, with peak plasma levels remaining extremely low (e.g., ~0.206 mcg/g after a 300 mg dose) and becoming undetectable within 12 hours.[24] Consequently, systemic toxicity from typical oral or topical use is not a concern, although ingestion can cause local gastric irritation.[24] Any absorbed drug is excreted almost entirely in the feces (~90%), with less than 1% appearing in the urine.[35]

The most critical pharmacokinetic property of chlorhexidine in dental applications is its substantivity. Following a standard 30-second oral rinse, approximately 30% of the active drug is retained in the oral cavity by binding to surfaces such as the tooth pellicle, oral mucosa, and salivary proteins.[24] This adsorbed reservoir of chlorhexidine is then slowly released back into the saliva over a prolonged period, typically 8 to 12 hours.[8] This sustained release maintains a therapeutic concentration of the antiseptic in the mouth long after the initial rinse, providing a lasting antimicrobial effect that inhibits plaque formation for many hours.

This property of substantivity is, however, a double-edged sword. It is the very foundation of chlorhexidine's prolonged clinical efficacy in controlling gingivitis, setting it apart from other oral antiseptics that are quickly cleared from the mouth. Yet, this same prolonged presence is the direct cause of its most common and compliance-limiting side effects. The continuous low-level release of the drug allows it to persistently interact with taste receptors, leading to the well-documented bitter aftertaste and altered taste perception.[2] Concurrently, the retained cationic chlorhexidine molecules are available to bind with anionic chromogens from dietary sources like coffee, tea, and red wine, as well as with the negatively charged salivary pellicle on the tooth surface, leading to the characteristic buildup of extrinsic brown stain.[2] Therefore, the very property that confers its clinical superiority is inextricably linked to the adverse effects that most challenge its use, presenting an inherent trade-off for both clinicians and patients.

Clinical Applications and Efficacy

Chlorhexidine's potent, broad-spectrum antimicrobial activity and favorable pharmacokinetic profile have led to its establishment as a vital agent in a wide range of clinical settings, spanning both dentistry and general medicine. Its applications are supported by decades of clinical use and a substantial body of evidence, though recent large-scale trials have begun to refine and, in some cases, challenge its universal supremacy.

Dental and Oral Health Applications

In dentistry, chlorhexidine is considered a cornerstone of chemical plaque control.

• Approved Indication: Gingivitis: The 0.12% chlorhexidine gluconate oral rinse is an FDA-approved prescription product indicated for use as part of a professional program for the treatment of gingivitis.[1] Used between dental visits, it effectively reduces the bacteria responsible for plaque, thereby decreasing gingival inflammation (redness), swelling, and bleeding on probing.[2] It is important to note that it is an adjunct to, not a replacement for, mechanical hygiene (brushing and flossing). Furthermore, while it treats the symptoms of gingivitis, it is not curative for the underlying bone loss associated with periodontitis and should not be used as the sole diagnostic indicator of periodontal health.[41]
• Approved Indication: Periodontitis: For patients with periodontitis, a 2.5 mg sustained-release chlorhexidine "chip" (e.g., PerioChip) is approved for insertion into periodontal pockets with a probing depth of 5 mm or greater.[1] Used as an adjunct to scaling and root planing (SRP), the chip slowly releases chlorhexidine over approximately 7-10 days to provide localized antimicrobial action, which has been shown to help reduce pocket depth.[1]
• Off-Label and Investigational Uses:
• Post-SRP Irrigation: A very common off-label use is the irrigation of periodontal pockets with chlorhexidine solution immediately following SRP.[8] The rationale is to eliminate residual pathogenic bacteria. However, this practice has become increasingly controversial. A significant disconnect exists between this common clinical practice and the substantial in vitro evidence demonstrating that chlorhexidine is cytotoxic to human gingival fibroblasts and osteoblasts—the very cells required for proper wound healing and tissue reattachment.[8] While effectively killing bacteria, the application of chlorhexidine directly to the post-surgical site may impair the desired biological outcome of forming a long junctional epithelium, representing a critical trade-off between antisepsis and tissue regeneration that warrants clinical reconsideration.
• Other Oral Uses: Chlorhexidine is also used in endodontics for root canal irrigation and as an intracanal dressing.[2] It has been used to manage conditions such as aphthous stomatitis (canker sores), oral candidiasis (especially as a denture soak), and halitosis.[45] Its role in preventing oral mucositis in cancer patients remains under investigation, with some studies showing benefit but overall results being inconsistent.[1]

Topical and Surgical Applications

Beyond the oral cavity, chlorhexidine is a workhorse antiseptic in general medical and surgical practice.

• Skin Antisepsis and Surgical Scrubs: Various formulations, typically containing 2% to 4% chlorhexidine (often combined with isopropyl alcohol), are indicated for preoperative skin preparation of patients, as a surgical hand scrub for healthcare personnel, and for general skin cleansing and wound cleaning.[1]
• Specialized Applications:
• Neonatal Care: A 2015 Cochrane review provided high-quality evidence that in community settings, particularly in developing countries, applying chlorhexidine to the umbilical cord stump significantly reduces the incidence of omphalitis (inflammation of the cord) and neonatal mortality.[2]
• Catheter Care: It is used to clean the skin around urinary catheter insertion sites to prevent infections and blockages.[2] It is also a standard of care for the preparation and maintenance of central venous catheter (CVC) sites, and is often impregnated into CVC dressings and the catheters themselves to reduce the risk of catheter-related bloodstream infections (CRBSIs).[53]

Comparative Efficacy and Clinical Trial Evidence

For many years, chlorhexidine has been considered superior to older antiseptics. Strong evidence supports that for clean surgery skin preparation, chlorhexidine-alcohol solutions are more effective at reducing surgical site infections (SSIs) than povidone-iodine.[2] However, recent evidence is refining this view.

A landmark multicenter randomized trial (PREPARE), published in the New England Journal of Medicine in 2024, directly compared an iodine-based antiseptic (0.7% iodine povacrylex in 74% isopropyl alcohol) with the standard 2% chlorhexidine gluconate in 70% isopropyl alcohol for fracture surgery.[55] In over 6,700 patients with closed fractures, the iodine-based solution led to a significantly lower rate of SSIs (2.4%) compared to the chlorhexidine solution (3.3%). This finding represents a major challenge to the universal preference for chlorhexidine and is likely to change clinical practice guidelines, at least in orthopedic trauma. For open fractures, there was no significant difference between the two agents.[55]

In the critical care setting, numerous trials have evaluated chlorhexidine oral care for the prevention of ventilator-associated pneumonia (VAP). While some studies demonstrate a reduction in oropharyngeal colonization by pathogens (particularly S. aureus), the effect on VAP rates is less clear, with some meta-analyses showing a benefit primarily in cardiac surgery patients.[56] Due to this uncertainty in the overall risk-benefit balance, major guidelines have stopped short of a formal, universal recommendation.[56]

The field remains active, with ongoing clinical trials investigating chlorhexidine in combination with other agents like cetylpyridinium chloride (CPC) for enhanced biofilm control, its use in colorectal surgery, and its impact on oral hygiene in intubated patients.[54]

Formulations, Dosage, and Administration Guidelines

The versatility of chlorhexidine is reflected in the vast array of commercially available formulations, each tailored to a specific clinical application. Correct dosage and administration are critical to maximize efficacy while minimizing adverse effects.

Commercial Formulations and Brand Names

Chlorhexidine is formulated as the active ingredient in hundreds of medical, dental, veterinary, and cosmetic products worldwide.[2] The table below summarizes the most common formulation types.

Formulation Type	Common Concentrations	Primary Use(s)	Example Brand Names
Oral Rinse/Mouthwash	0.12%, 0.2%	Gingivitis, pre-procedural rinse	Peridex, Periogard, Corsodyl, Paroex 1
Periodontal Chip	2.5 mg (sustained release)	Periodontitis adjunct	PerioChip 1
Topical Solution/Scrub	0.5%, 2%, 4% (often with alcohol)	Skin antisepsis, surgical scrub	Hibiclens, Betasept, ChloraPrep 1
Sponge/Swab/Towelette	2%, 4%, 0.5% (with alcohol)	Pre-operative skin prep	ChloraPrep, Hibistat 1
Gel/Cream/Lotion	0.2%, 1%	Wound dressing, skin cleansing	Elugel, Dermol, Savlon 2
Lozenges	5mg (often with lidocaine)	Sore throat	Covonia, Angal 61

Globally, chlorhexidine is marketed under a multitude of brand names, including Abihex (India), Anzibel (Bosnia), Cyteal (Slovakia), Dentisept (Veterinary, Germany), Eludril (Tunisia), and Geksikon (Latvia), among many others.[63]

Major Manufacturers

The global market for chlorhexidine is served by several key manufacturers of both the active pharmaceutical ingredient (API) and finished products. Prominent companies include:

• Medichem S.A.: A major Spanish-based API supplier manufacturing chlorhexidine salts since 1985.[64]
• Xttrium Laboratories, Inc.: A leading US-based manufacturer of generic 0.12% chlorhexidine oral rinse and topical antiseptic solutions.[66]
• 3M (now Solventum): Manufacturer of the well-known Peridex brand of oral rinse.[66]
• Other significant players in the market for chlorhexidine-containing products include Ecolab, Mölnlycke Health Care, Becton, Dickinson and Company (BD), and Dentsply Sirona.[66]

Dosage and Administration

Adherence to proper dosing and administration techniques is essential for achieving the desired clinical outcome and ensuring patient safety.

Indication	Formulation	Dosage and Administration	Key Instructions	Source(s)
Gingivitis	0.12% Oral Rinse	Rinse with 15 mL (marked cap or 1/2 oz) for 30 seconds, twice daily (morning and evening).	Use after brushing and flossing. Spit out; do not swallow. Do not rinse with water, eat, or drink for at least 30 minutes after use to preserve substantivity.	6
Periodontitis	2.5 mg Periodontal Chip	A dental professional inserts one chip into a periodontal pocket ≥5mm deep. May be repeated every 3 months. Maximum of 8 chips per visit.	Avoid flossing at the insertion site for 10 days to prevent dislodgement.	37
Surgical Hand Scrub	4% Solution/Scrub	Wet hands and forearms. Scrub vigorously for 3 minutes with approximately 5 mL of product. Rinse thoroughly. Repeat the wash for an additional 3 minutes. Dry with a sterile towel.	Pay close attention to nails, cuticles, and interdigital spaces.	49
Patient Pre-op Skin Prep	2-4% Solution	Apply liberally to the surgical site and swab for at least 2 minutes. Allow the area to air dry completely. Do not blot or wipe dry.	Do not allow the solution to pool. Avoid use on the head, face, or in situations with potential contact with the meninges. Use with care in infants <2 months of age.	7

Comprehensive Safety Profile and Risk Management

While chlorhexidine is generally considered safe and is listed as an essential medicine, its use is associated with a range of adverse effects from common and manageable to rare and life-threatening. A comprehensive understanding of this safety profile is critical for responsible clinical use.

Common and Predictable Adverse Effects

These effects are well-documented and primarily associated with the formulation and site of application.

• Oral Use:
• Staining: The most frequently reported side effect of the oral rinse is an extrinsic, brownish staining of teeth, composite restorations, and the dorsum of the tongue.[2] The intensity of staining is exacerbated by poor oral hygiene (heavy plaque accumulation) and the consumption of chromogenic substances like coffee, tea, and red wine.[38] While this stain is not harmful and can typically be removed by professional dental prophylaxis, it can be permanent on restorations with rough surfaces or open margins, which may necessitate their replacement.[38]
• Calculus Formation: Users of chlorhexidine rinse often experience an increase in the formation of supragingival tartar (calculus).[6] This necessitates regular professional dental cleanings at intervals not exceeding six months.[24]
• Taste Alteration (Dysgeusia): A persistent bitter aftertaste and a temporary alteration in taste perception are very common.[2] This effect can last for several hours after rinsing. While it usually diminishes with continued use and resolves upon discontinuation, rare instances of permanent taste alteration have been reported in post-marketing surveillance.[42]
• Oral Mucosal Irritation: Less frequently, patients may experience peeling of the oral mucosa (desquamation), a burning sensation, tongue irritation, dry mouth, or the development of aphthous ulcers.[6]
• Topical Use:
• Skin Irritation: Topical application can cause localized skin irritation, dermatitis, redness, itching, or a burning sensation.[2] This is more likely to occur in sensitive skin folds or in premature infants and children under two months of age, in whom severe irritation and chemical burns have been reported.[50]

Contraindications and Precautions

Strict adherence to contraindications and precautions is essential to prevent serious harm.

• Absolute Contraindication: The primary contraindication for any chlorhexidine product is a known history of hypersensitivity or allergy to chlorhexidine gluconate or any other component in the formulation.[42]
• Major Precautions and Warnings:
• Meningeal Contact: Chlorhexidine must not be used for lumbar puncture or in any procedure where it might come into contact with the meninges (the membranes covering the brain and spinal cord). This warning is based on historical animal studies demonstrating neurotoxicity and is a critical safety measure to prevent severe central nervous system injury.[52]
• Ocular and Otic Exposure: The agent must be kept out of the eyes and ears. Direct contact with the eye, especially during surgical procedures, can cause severe and permanent corneal injury. If instilled into the middle ear through a perforated eardrum, it can cause deafness.[2]
• Pediatric Use: Due to the risk of skin irritation and chemical burns, chlorhexidine topical products should be used with care in infants younger than 2 months.[7] The safety and efficacy of the 0.12% oral rinse have not been established in children under the age of 18.[6]

Severe Hypersensitivity and Anaphylaxis: A Major Safety Concern

The most serious risk associated with chlorhexidine is the potential for a severe, life-threatening allergic reaction.

• 2017 FDA Drug Safety Communication: In a landmark safety action, the FDA issued a warning in February 2017 regarding rare but serious and potentially fatal anaphylactic reactions associated with topical over-the-counter chlorhexidine products.[10] This was driven by a clear increase in the number of adverse event reports, with more than half of all cases reported to the FDA between 1969 and 2015 occurring after 2010.[10] The FDA mandated that manufacturers add a warning about this risk to product labels.[10]
• Nature of the Reaction: Anaphylaxis to chlorhexidine is a classic Type I, IgE-mediated immediate hypersensitivity reaction, which can manifest within minutes of exposure.[10] Symptoms are systemic and severe, including wheezing or difficulty breathing, swelling of the face and throat (angioedema), widespread hives (urticaria), severe rash, and a rapid drop in blood pressure leading to life-threatening shock.[10]
• Prevalence and Risk Factors: While the absolute risk remains low, the frequency of reported cases is rising globally.[10] Chlorhexidine is now recognized as one of the leading causes of perioperative anaphylaxis, ranking third in a major UK audit, behind only antibiotics and neuromuscular blocking agents.[80] The risk of sensitization and subsequent reaction is thought to be highest when chlorhexidine is applied to mucous membranes or non-intact skin.[80]
• Clinical Implications and the "Hidden Allergen": The rising incidence of chlorhexidine anaphylaxis may be an iatrogenic phenomenon, inadvertently driven by its own success and ubiquity. Its incorporation into countless medical products—from skin preps and oral rinses to coatings on central venous catheters, lubricating gels, and wound dressings—has created a healthcare environment saturated with the allergen.[4] This constant, often unrecognized, exposure provides numerous opportunities for individuals to become sensitized. A patient might develop a sensitivity from a chlorhexidine-impregnated catheter dressing during one hospital stay and then experience a full-blown anaphylactic reaction to a pre-surgical skin prep years later. This transforms the risk from a simple drug-specific property into a complex public health and systems-level problem of managing a "hidden allergen".[82] Consequently, it is now imperative for clinicians to actively screen all patients for a history of allergy to any antiseptic before using a chlorhexidine product and to be prepared to use alternatives like povidone-iodine or alcohol if a sensitivity is suspected.[11]

Cytotoxicity and Impact on Wound Healing

Beyond allergic reactions, emerging research has focused on the cytotoxic potential of chlorhexidine at the cellular level. Multiple in vitro studies have demonstrated that chlorhexidine can be toxic to key cells involved in tissue repair, including human gingival fibroblasts and osteoblasts.[8] It has been shown to negatively affect cell viability, adhesion, and proliferation. These findings raise significant questions about the wisdom of using chlorhexidine in clinical situations where optimal tissue regeneration is the primary goal, such as irrigating a surgical site or a periodontal pocket after debridement, as it may paradoxically impair the healing process it is intended to protect.[8]

Drug and Chemical Interactions

The efficacy and safety of chlorhexidine can be significantly influenced by its interactions with other chemicals, drugs, and dietary components. These interactions are primarily chemical or localized in nature, as its poor systemic absorption limits the potential for systemic pharmacological interactions.

Chemical Incompatibilities and Inactivation

Chlorhexidine's cationic nature is the source of its most important chemical incompatibilities.

• Anionic Compounds in Toothpaste: Chlorhexidine is chemically incompatible with anionic compounds commonly found in dentifrices, such as the surfactant sodium lauryl sulfate (SLS) and the fluoride source sodium monofluorophosphate.[2] When mixed, the positive charge of chlorhexidine is neutralized by these anions, forming insoluble salts that have greatly reduced or no antibacterial activity. This is a critical clinical interaction. To prevent this inactivation and ensure the efficacy of the rinse, patients must be explicitly instructed to wait a minimum of 30 minutes, and ideally up to two hours, after toothbrushing before using a chlorhexidine rinse. Alternatively, they should rinse their mouth thoroughly with water after brushing to remove toothpaste residue before using the chlorhexidine product.[2]
• Sodium Hypochlorite (NaOCl): In the field of endodontics, the concurrent use of chlorhexidine and sodium hypochlorite (bleach) as root canal irrigants is strongly contraindicated without an intermediate flushing step. When these two solutions are mixed, they react to form a thick, orange-brown, insoluble precipitate.[31] This precipitate contains p-chloroaniline (PCA), a substance with known cytotoxic and potentially mutagenic properties. The precipitate also forms a chemical smear layer that can occlude the dentinal tubules, physically interfering with the proper sealing of the root canal filling.[31] To avoid this harmful interaction, the root canal must be thoroughly flushed with a neutral solution like saline, sterile water, or alcohol between the use of NaOCl and a final rinse with chlorhexidine.
• Other Inactivators: The efficacy of chlorhexidine can also be diminished by other anionic compounds used as excipients in pharmaceutical and cosmetic products, such as the gelling agent carbomer and certain anionic emulsifiers.[2]

Pharmacological Drug Interactions

Given that chlorhexidine is minimally absorbed systemically when used as an oral rinse or topical agent, clinically significant drug-drug interactions are rare and largely theoretical. The interactions noted in pharmacological databases are typically based on the potential for swallowed chlorhexidine to alter the gut microbiome, which could theoretically affect the absorption or metabolism of other orally administered drugs.[37]

Interacting Agent	Potential Effect	Mechanism	Clinical Significance & Recommendation	Source(s)
allogeneic cultured keratinocytes/fibroblasts	Decreased effect of the agent	Degradation of the cellular product by the antiseptic.	Contraindicated. Exposure to antiseptics degrades the product. Avoid combination.	37
Live Bacterial Vaccines (e.g., BCG, oral Typhoid)	Decreased vaccine efficacy	Pharmacodynamic antagonism due to antibacterial activity.	Serious. Avoid concurrent use. Ensure antiseptic therapy is complete before administering the live vaccine.	37
Digoxin (oral)	Potentially increased digoxin levels	Alteration of intestinal flora (e.g., reduction of Eubacterium lentum which metabolizes digoxin).	Monitor Closely. Risk is considered low due to poor absorption of chlorhexidine, but caution is warranted.	37
Oral Estrogens (e.g., estradiol, conjugated estrogens)	Potentially decreased estrogen levels	Alteration of intestinal flora, potentially disrupting enterohepatic circulation.	Monitor Closely. Risk of contraceptive failure is considered low, but should be noted.	37
Various Vitamins & Prodrugs (e.g., biotin, vitamin K, balsalazide)	Potentially decreased levels or effects	Alteration of intestinal flora.	Minor. Clinical significance is unknown and likely negligible with standard use.	37

Food Interactions

There are no systemic food-drug interactions. However, local interactions within the oral cavity are significant for both efficacy and side effects.

• Chromogenic Foods and Beverages: The consumption of substances with strong chromogens, such as coffee, tea, and red wine, is known to significantly enhance the extrinsic tooth staining caused by chlorhexidine rinse.[40] Patients should be counseled to avoid these items or to time their consumption at least one hour before or after using the rinse to minimize this effect.
• Taste Interference and Post-Rinse Protocol: To mitigate the unpleasant taste alteration, patients are often advised to use the chlorhexidine rinse after meals.[35] It is critical that patients do not eat, drink, or rinse their mouth with water immediately after using the medication. Doing so not only increases the perception of the bitter taste but, more importantly, rinses away the retained drug, negating its substantivity and reducing its clinical effectiveness.[2]

Current Research and Future Directions

The scientific inquiry into chlorhexidine, a compound in use for over 70 years, is far from static. Modern research is moving beyond simply confirming its antimicrobial efficacy to exploring its broader ecological impacts on both the patient and the healthcare environment. This new frontier of research is revealing previously underappreciated risks and novel potential applications.

Impact on the Human Microbiome

The traditional understanding of chlorhexidine as a non-specific biocide is being replaced by a more nuanced view of its role as a powerful modulator of microbial communities.

• Recent studies utilizing advanced genomic sequencing have shown that chlorhexidine does not merely reduce bacterial numbers but actively shifts the composition and metabolic function of the oral microbiome. One study reported that its use led to a decrease in salivary nitrate concentrations, which could have implications for cardiovascular health, alongside an increase in salivary lactate and glucose. This suggests a shift toward a more acidogenic (acid-producing) oral environment.[47]
• A 2024 study on skin antisepsis provided a critical update. Using viability-based sequencing methods, researchers found that while preoperative application of CHG does significantly reduce the viable microbial bioburden on the skin, it does not achieve complete sterility. Importantly, the post-CHG skin environment showed a temporary enrichment of potentially pathogenic and CHG-tolerant taxa, such as Bacillus species.[92] This indicates that chlorhexidine acts as a strong selective pressure, altering the microbial landscape rather than simply clearing it.

Environmental Persistence and Bacterial Tolerance

A significant and emerging area of research concerns the environmental fate of chlorhexidine and its potential to drive antimicrobial resistance.

• Chlorhexidine is shed from treated patients onto hospital surfaces like bed rails and tables. Recent studies have demonstrated that it can persist in the built environment at sublethal concentrations, even after routine cleaning and disinfection procedures.[93]
• This environmental persistence creates a low-dose, long-term selective pressure on environmental bacteria. This raises serious concerns that such exposure could lead to the selection and proliferation of bacteria with reduced susceptibility (tolerance) to chlorhexidine. Furthermore, there is evidence that tolerance to chlorhexidine can be linked to cross-resistance to clinically vital antibiotics, such as the last-resort antibiotic colistin.[47] This places the routine use of chlorhexidine within the broader "One Health" framework, which recognizes the interconnectedness of human health, animal health, and the environment in the global challenge of antimicrobial resistance. The evaluation of chlorhexidine can no longer be confined to the patient-pathogen interaction; its ecological consequences must be considered.

Novel Applications and Re-evaluation of Efficacy

Research continues to identify new potential uses for this old drug, while also critically re-evaluating its role in established practices.

• COVID-19: During the pandemic, the antiviral properties of chlorhexidine against enveloped viruses prompted research into its use as an oral rinse to reduce oropharyngeal shedding of SARS-CoV-2. One clinical study found that a chlorhexidine rinse significantly reduced the presence of the virus in the oropharynx of COVID-19 patients, suggesting it could serve as a simple and safe adjunct to other preventive measures to decrease disease transmission.[34]
• Novel Formulations: Material science research is focused on developing advanced chlorhexidine delivery systems. One promising approach involves the co-precipitation of chlorhexidine with therapeutic metal ions, such as strontium (Sr2+) and zinc (Zn2+). This creates novel particles that can provide a responsive, pH-dependent release of both the antiseptic and the beneficial ions, offering a potential "smart" delivery system for applications in medicine and dentistry.[94]
• Challenging the "Gold Standard": The PREPARE trial's 2024 finding that an iodine-based antiseptic was superior to chlorhexidine for preventing surgical site infections in closed fractures represents a pivotal moment in the field of surgical antisepsis.[55] It powerfully demonstrates that no single antiseptic is universally optimal. This is driving a shift toward a more evidence-based, procedure-specific approach to antiseptic selection, where the choice of agent is tailored to the type of surgery, the patient's anatomy, and the local microbial epidemiology.

Regulatory History

The regulatory journey of chlorhexidine in the United States reflects its evolution from a novel discovery to a ubiquitous, essential medicine, and now to a compound with a well-documented, serious, albeit rare, safety concern.

• Discovery and Introduction: Chlorhexidine was discovered in the 1950s by Imperial Chemical Industries in the UK and was first introduced commercially there in 1954 as a topical antiseptic.[1] It was subsequently introduced into the United States market during the 1970s.[1]
• FDA Approvals and Clearances: Over the subsequent decades, the FDA has granted approvals and clearances for a wide variety of chlorhexidine-containing products. Key milestones include the clearance of the first urology lubricant with chlorhexidine in 1981, the first combination chlorhexidine-and-alcohol skin preparation in 1988, and the first chlorhexidine-impregnated wound dressing in 1993.[4] A New Drug Application (NDA 021669) for a 0.12% chlorhexidine gluconate oral rinse was formally approved on April 25, 2005.[95] The FDA's oversight remains rigorous, with continued scrutiny of manufacturing processes, sterility assurance, and impurity levels in new product applications, as evidenced by a detailed 2018 review of a chlorhexidine/isopropyl alcohol product (NDA 208288).[32]
• FDA Safety Communications and Labeling Changes:
• 1998 Public Health Notice: The FDA's first major safety communication regarding chlorhexidine was a Public Health Notice issued in 1998. It warned healthcare professionals of the risk of serious allergic reactions associated with medical devices that contained chlorhexidine, such as intravenous lines and dressings.[11]
• 2017 Drug Safety Communication: The most significant regulatory action occurred on February 2, 2017, when the FDA issued a Drug Safety Communication warning about rare but serious and potentially fatal allergic reactions to over-the-counter (OTC) topical antiseptic products containing chlorhexidine gluconate.[10] Citing an increasing number of adverse event reports, the agency requested that manufacturers add a prominent warning about this risk to the Drug Facts label of all such OTC products. At the time, prescription oral rinse products already contained a similar warning in their labeling.[11]
• Meninges Warning: Based on early animal studies showing neurotoxicity, all chlorhexidine-based topical skin antiseptics carry a specific warning on their labels stating they should not be used for lumbar puncture or in any situation where contact with the meninges is possible.[52]
• Product Withdrawal: The FDA has also acted to remove specific formulations from the market when safety concerns arose. Notably, it withdrew its approval for chlorhexidine gluconate topical tincture 0.5% due to a significant number of reports linking its use to chemical and thermal burns.[1]

Expert Synthesis and Recommendations

Chlorhexidine remains an indispensable and highly effective antiseptic in the modern healthcare armamentarium. Its broad-spectrum activity, persistent effect, and long history of use rightfully support its status as an essential medicine. However, the perception of chlorhexidine as a universally safe and superior agent must be tempered by a nuanced, evidence-based understanding of its significant, albeit often rare, risks. The contemporary view of chlorhexidine is one of a powerful tool whose application requires careful consideration and risk stratification. The historical confidence in its safety is now challenged by compelling evidence of severe anaphylactic reactions, well-documented cytotoxic properties that may impair tissue healing, and a complex ecological impact on both the patient's microbiome and the broader hospital environment.

Based on this comprehensive analysis, the following recommendations are put forth for clinical practice:

1. Mandatory Allergy Screening: In alignment with FDA guidance, clinicians must universally adopt the practice of actively screening patients for any history of allergic reactions to antiseptics before prescribing or using any product containing chlorhexidine. A simple question—"Have you ever had a rash or reaction to a skin disinfectant, surgical soap, or medicated mouthwash?"—should become a standard part of the pre-procedural checklist.
2. Risk-Stratified and Evidence-Based Antiseptic Selection: The choice of antiseptic should not be reflexive but should be tailored to the specific clinical scenario.

• For orthopedic surgery involving closed fractures, clinicians should strongly consider using an iodine povacrylex-alcohol solution, based on the high-quality evidence from the PREPARE trial demonstrating its superiority in reducing surgical site infections.[55]
• For procedures where optimal soft tissue regeneration is paramount, such as following periodontal scaling and root planing, the known in vitro cytotoxicity of chlorhexidine to fibroblasts must be weighed against its antimicrobial benefits. The routine, off-label use of chlorhexidine as a subgingival irrigant should be critically re-evaluated in favor of agents with a more favorable profile for wound healing.

3. Informed and Thorough Patient Counseling: Patients who are prescribed chlorhexidine oral rinse require clear and specific instructions to maximize efficacy and minimize harm. Counseling must include:

• The critical importance of the waiting period (at least 30 minutes) between brushing with anionic toothpaste and using the rinse to prevent inactivation.
• Setting realistic expectations regarding the high likelihood of manageable side effects, particularly extrinsic staining and taste alteration, and the need for regular professional cleanings.
• Clear instructions on the signs and symptoms of an allergic reaction (e.g., rash, hives, swelling, difficulty breathing) and the imperative to stop the product and seek immediate medical attention should they occur.

4. Unyielding Adherence to Safety Contraindications: The warnings against use near the eyes, ears, and meninges are absolute. Strict protocols must be in place in all clinical settings, particularly operating rooms and procedural suites, to prevent accidental exposure and the risk of severe, irreversible iatrogenic injury.

The future of chlorhexidine in clinical practice will be defined by greater precision. Its enduring utility is not in question, but its application must evolve. Future research should prioritize the development of novel formulations that can decouple its potent antimicrobial action from its cytotoxic effects, deepen the understanding of bacterial tolerance mechanisms to mitigate the risk of resistance, and continue to conduct large-scale, comparative-effectiveness trials to clearly define its optimal role among a growing portfolio of antiseptic agents. The story of chlorhexidine serves as a powerful reminder that even for our most established and trusted medicines, scientific understanding is a continuous process of discovery, refinement, and vigilance.

Works cited

1. Chlorhexidine: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed July 21, 2025, https://go.drugbank.com/drugs/DB00878
2. Chlorhexidine - Wikipedia, accessed July 21, 2025, https://en.wikipedia.org/wiki/Chlorhexidine
3. Chlorhexidine | C22H30Cl2N10 | CID 9552079 - PubChem, accessed July 21, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Chlorhexidine
4. History of Chlorhexidine, accessed July 21, 2025, https://www.chlorhexidinefacts.com/history-of-chlorhexidine.html
5. Chlorhexidine | 55-56-1 - ChemicalBook, accessed July 21, 2025, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB4732251.htm
6. Chlorhexidine (oral route) - Side effects & dosage - Mayo Clinic, accessed July 21, 2025, https://www.mayoclinic.org/drugs-supplements/chlorhexidine-oral-route/description/drg-20068551
7. Chlorhexidine (topical application route) - Side effects & dosage - Mayo Clinic, accessed July 21, 2025, https://www.mayoclinic.org/drugs-supplements/chlorhexidine-topical-application-route/description/drg-20070874
8. Chlorhexidine: An Update - Today's RDH, accessed July 21, 2025, https://www.todaysrdh.com/chlorhexidine-an-update/
9. Chlorhexidine Facts: Home, accessed July 21, 2025, https://www.chlorhexidinefacts.com/
10. FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate, accessed July 21, 2025, https://www.fda.gov/media/102986/download
11. Chlorhexidine Gluconate Drug Safety Communication Rare But Serious Allergic Reactions, accessed July 21, 2025, https://www.asahq.org/advocacy-and-asapac/fda-and-washington-alerts/fda-alerts/2017/02/chlorhexidine-gluconate-drug-safety-communication-rare-but-serious-allergic-reactions
12. FDA Drug Safety Podcast: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate, accessed July 21, 2025, https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-drug-safety-podcast-fda-warns-about-rare-serious-allergic-reactions-skin-antiseptic
13. CHEBI:3614 - chlorhexidine - EMBL-EBI, accessed July 21, 2025, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3614
14. Chlorhexidine | C22H30Cl2N10 - ChemSpider, accessed July 21, 2025, https://www.chemspider.com/Chemical-Structure.2612.html
15. Chlorhexidine - Agricultural Marketing Service, accessed July 21, 2025, https://www.ams.usda.gov/sites/default/files/media/Chlorhexidine%20TR%202015.pdf
16. pubchem.ncbi.nlm.nih.gov, accessed July 21, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Chlorhexidine#:~:text=Chlorhexidine%20is%20a%20bisbiguanide%20compound,functionally%20related%20to%20a%20biguanide.
17. Chemical structure of chlorhexidine (C22H30Cl2N10). | Download ..., accessed July 21, 2025, https://www.researchgate.net/figure/Chemical-structure-of-chlorhexidine-C22H30Cl2N10_fig1_267099100
18. Chlorhexidine, 98%, Thermo Scientific Chemicals, accessed July 21, 2025, https://www.thermofisher.com/order/catalog/product/es/en/461020050
19. Chlorhexidine (CAS 55-56-1) - Glentham Life Sciences, accessed July 21, 2025, https://www.glentham.com/en/products/product/GP9341/
20. Chlorhexidine = 99.5 55-56-1 - Sigma-Aldrich, accessed July 21, 2025, https://www.sigmaaldrich.com/US/en/product/aldrich/282227
21. Chlorhexidine - CAS RN: 55-56-1 - TCI Chemicals, accessed July 21, 2025, https://www.tcichemicals.com/US/en/p/C2530
22. Chlorhexidine gluconate | DrugBank Online, accessed July 21, 2025, https://go.drugbank.com/salts/DBSALT000023
23. Chlorhexidine - American Chemical Society, accessed July 21, 2025, https://www.acs.org/molecule-of-the-week/archive/c/chlorhexidine.html
24. CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP - DailyMed, accessed July 21, 2025, https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=923e22b1-0fa2-4a3c-900d-2d2eb63f841c&type=display
25. Chlorhexidine (digluconate) | C34H54Cl2N10O14 | CID 5360565 - PubChem, accessed July 21, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Chlorhexidine-_digluconate
26. chlorhexidine gluconate solution usp (30-4323) - PCCA, accessed July 21, 2025, https://www.pccarx.com/products/CHLORHEXIDINEGLUCONATESOLUTIONUSP/30-4323/APIS-EXCIPIENTS
27. Chlorhexidine: Human health tier II assessment, accessed July 21, 2025, https://www.industrialchemicals.gov.au/sites/default/files/Chlorhexidine_Human%20health%20tier%20II%20assessment.pdf
28. Chlorhexidine = 98 3697-42-5 - Sigma-Aldrich, accessed July 21, 2025, https://www.sigmaaldrich.com/US/en/product/aldrich/c8527
29. Chlorhexidine 2HCl | 99.75%(HPLC) | In Stock | Anti-infection chemical, accessed July 21, 2025, https://www.selleckchem.com/products/chlorhexidine-hcl.html
30. CN102993056A - Preparation method of chlorhexidine compound - Google Patents, accessed July 21, 2025, https://patents.google.com/patent/CN102993056A/en
31. Agonistic and Antagonistic Interactions between Chlorhexidine and Other Endodontic Agents: A Critical Review - PMC - PubMed Central, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4293573/
32. 208288Orig1s000 - accessdata.fda.gov, accessed July 21, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/208288Orig1s000MedR.pdf
33. CN118184592A - Preparation method of chlorhexidine impurity J gluconate - Google Patents, accessed July 21, 2025, https://patents.google.com/patent/CN118184592A/en
34. Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients - PMC, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8251493/
35. Peridex (chlorhexidine gluconate) solution label - accessdata.fda.gov, accessed July 21, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019028s022lbl.pdf
36. Chlorhexidine gluconate oral rinse Uses, Side Effects & Warnings - Drugs.com, accessed July 21, 2025, https://www.drugs.com/mtm/chlorhexidine-gluconate-oral-rinse.html
37. Peridex, PerioGard (chlorhexidine oral) dosing, indications ..., accessed July 21, 2025, https://reference.medscape.com/drug/peridex-periogard-chlorhexidine-oral-342557
38. Contraindications for Chlorhexidine - Dimensions of Dental Hygiene, accessed July 21, 2025, https://dimensionsofdentalhygiene.com/questions/contraindications-for-chlorhexidine/
39. The Gold Standard Oral Antimicrobial Rinse: Chlorhexidine Gluconate, accessed July 21, 2025, https://www.colgateprofessional.com/students-faculty/faculty-resources/the-gold-standard-oral-antimicrobial-rinse-chlorhexidine-gluconate
40. www.peacehealth.org, accessed July 21, 2025, https://www.peacehealth.org/medical-topics/id/hn-1104006#:~:text=Controlled%20studies%20show%20that%20drinking,they%20avoid%20these%20beverages%20altogether.
41. Chlorhexidine oral rinse (Peridex, PerioGard, and others): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD, accessed July 21, 2025, https://www.webmd.com/drugs/2/drug-5356/chlorhexidine-gluconate-mouth-and-throat/details
42. Chlorhexidine: Package Insert / Prescribing Information - Drugs.com, accessed July 21, 2025, https://www.drugs.com/pro/chlorhexidine.html
43. Chlorhexidine (EENT) Monograph for Professionals - Drugs.com, accessed July 21, 2025, https://www.drugs.com/monograph/chlorhexidine-eent.html
44. Chlorhexidine Oral Rinse: How to Use - Cleveland Clinic, accessed July 21, 2025, https://my.clevelandclinic.org/health/drugs/19199-chlorhexidine-oral-rinse
45. Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects - PMC, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9275362/
46. www.todaysrdh.com, accessed July 21, 2025, https://www.todaysrdh.com/chlorhexidine-an-update/#:~:text=Because%20of%20these%20strong%20antimicrobial,the%20freshly%20scaled%20root%20surface.
47. Is Chlorhexidine in Dentistry an Ally or a Foe? A Narrative Review - MDPI, accessed July 21, 2025, https://www.mdpi.com/2227-9032/10/5/764
48. Stomatitis, Aphthous Completed Phase Trials for Chlorhexidine (DB00878) - DrugBank, accessed July 21, 2025, https://go.drugbank.com/indications/DBCOND0001943/clinical_trials/DB00878?status=completed
49. Betasept, Hibiclens (chlorhexidine topical) dosing, indications, interactions, adverse effects, and more. - Medscape Reference, accessed July 21, 2025, https://reference.medscape.com/drug/betasept-hibiclens-chlorhexidine-topical-999599
50. Hibiclens Dosage Guide - Drugs.com, accessed July 21, 2025, https://www.drugs.com/dosage/hibiclens.html
51. Label: CHLORHEXIDINE GLUCONATE- antiseptic skin cleanser gel - DailyMed, accessed July 21, 2025, https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=673abf62-7774-6af1-e053-2a91aa0afc52
52. Antiseptic Skin Cleanser(Chlorhexidine Gluconate 4% Solution) - DailyMed, accessed July 21, 2025, https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=76cfedb3-25ed-4c12-8ebc-b57f029fedaa
53. Chlorhexidine use in the Neonatal Intensive Care Unit: Results from a National Survey, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2900383/
54. Search for: Chlorhexidine | Card Results | ClinicalTrials.gov, accessed July 21, 2025, https://clinicaltrials.gov/search?cond=Chlorhexidine&viewType=Table
55. Large Multicenter Clinical Trial Finds that Antiseptic Containing Iodine Reduces Surgical-Site Infections in Patients with Extremity Fractures | University of Maryland School of Medicine, accessed July 21, 2025, https://www.medschool.umaryland.edu/news/2024/large-multicenter-clinical-trial-finds-that-antiseptic-containing-iodine-reduces-surgical-site-infections-in-patients-with-extremity-fractures--.html
56. Chlorhexidine for Oral Care: A Review of Clinical Effectiveness and Guidelines - NCBI, accessed July 21, 2025, https://www.ncbi.nlm.nih.gov/books/NBK541430/
57. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients - PMC - PubMed Central, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2750165/
58. Clinical Effects of Two New Chlorhexidine Digluconate - ClinConnect, accessed July 21, 2025, https://clinconnect.io/trials/NCT02194023
59. en.wikipedia.org, accessed July 21, 2025, https://en.wikipedia.org/wiki/Chlorhexidine#:~:text=Society%20and%20culture-,Brands,Corsodyl%20and%20Periogard%2C%20among%20others.
60. Chlorhexidine Topical: Side Effects, Uses, Dosage, Interactions, Warnings - RxList, accessed July 21, 2025, https://www.rxlist.com/chlorhexidine_topical/generic-drug.htm
61. How and when to use chlorhexidine - NHS, accessed July 21, 2025, https://www.nhs.uk/medicines/chlorhexidine/how-and-when-to-use-chlorhexidine/
62. Chlorhexidine: antiseptic and disinfectant for mouth ulcers, throat infections and skin infections - NHS, accessed July 21, 2025, https://www.nhs.uk/medicines/chlorhexidine/
63. Chlorhexidine (International database) - Drugs.com, accessed July 21, 2025, https://www.drugs.com/international/chlorhexidine.html
64. Chlorhexidine API | Medichem - GMP-Grade Antiseptic APIs, accessed July 21, 2025, https://www.medichem.es/product/chlorhexidine-api/
65. Medichem - Chlorhexidine Facts, accessed July 21, 2025, https://www.chlorhexidinefacts.com/medichem.html
66. E: Search: chlorhexidine - Page 1 of 2 - DHP, accessed July 21, 2025, https://www.dhpsupply.com/products/?pSearch=chlorhexidine&psType=E
67. Contract Manufacturing - Xttrium, accessed July 21, 2025, https://www.xttrium.com/contract-manufacturing/
68. Global Chlorhexidine Gluconate (CHG) Solution Competitive, accessed July 21, 2025, https://www.marketresearch.com/Deep-Insights-Research-Co-DIR-v4285/Global-Chlorhexidine-Gluconate-CHG-Solution-39403158/
69. Chlorhexidine mouth rinse: MedlinePlus Drug Information, accessed July 21, 2025, https://medlineplus.gov/druginfo/meds/a625015.html
70. Chlorhexidine (Peridex): Uses, Side Effects, Warnings & More - GoodRx, accessed July 21, 2025, https://www.goodrx.com/chlorhexidine/what-is
71. Chlorhexidine Topical Dosage Guide + Max Dose, Adjustments - Drugs.com, accessed July 21, 2025, https://www.drugs.com/dosage/chlorhexidine-topical.html
72. Pre-operative shower using chlorhexidine gluconate (CHG) | University of Iowa Health Care, accessed July 21, 2025, https://uihc.org/educational-resources/pre-operative-shower-using-chlorhexidine-gluconate-chg
73. Adverse events associated with chlorhexidine use: results from the Department of Veterans Affairs Dental Diabetes Study - PubMed, accessed July 21, 2025, https://pubmed.ncbi.nlm.nih.gov/18245686/
74. Chlorhexidine – Health Information Library | PeaceHealth, accessed July 21, 2025, https://www.peacehealth.org/medical-topics/id/hn-1104006
75. Side effects of chlorhexidine - NHS, accessed July 21, 2025, https://www.nhs.uk/medicines/chlorhexidine/side-effects-of-chlorhexidine/
76. www.nhs.uk, accessed July 21, 2025, https://www.nhs.uk/medicines/chlorhexidine/side-effects-of-chlorhexidine/#:~:text=Side%20effects%20of%20chlorhexidine%20skin,on%20brown%20or%20black%20skin.
77. www.drugs.com, accessed July 21, 2025, https://www.drugs.com/pro/chlorhexidine.html#:~:text=periodontitis%2C%20see%20PRECAUTIONS.-,Contraindications,gluconate%20or%20other%20formula%20ingredients.
78. Chlorhexidine Question May Be For FDA - Anesthesia Patient Safety Foundation, accessed July 21, 2025, https://www.apsf.org/article/chlorhexidine-question-may-be-for-fda/
79. FDA Drug Safety Communication: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate - Moda Health, accessed July 21, 2025, https://modahealth.com/medical/drug_warnings/2017/chlorhexidine_gluconate.shtml
80. c8 Chlorhexidine - Thermo Fisher Scientific, accessed July 21, 2025, https://www.thermofisher.com/phadia/wo/en/resources/allergen-encyclopedia/c8.html
81. Immediate hypersensitivity to chlorhexidine is increasingly recognised in the United Kingdom | Allergologia et Immunopathologia - Elsevier, accessed July 21, 2025, https://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-articulo-immediate-hypersensitivity-chlorhexidine-is-increasingly-S0301054612002625
82. Chlorhexidine Allergy Frequently Asked Questions, accessed July 21, 2025, https://www.allergy.org.au/images/pc/ASCIA_PC_Chlorhexidine_Allergy_2024.pdf
83. www.allergy.org.au, accessed July 21, 2025, https://www.allergy.org.au/patients/drug-allergy/chlorhexidine-allergy#:~:text=Allergic%20reactions%20to%20chlorhexidine%20are%20rare%20but%20are%20increasing%20in,%2C%20and%20angioedema%20(swelling).
84. 17 Chlorhexidine - National Audit Projects (NAPs), accessed July 21, 2025, https://www.nationalauditprojects.org.uk/downloads/NAP6%20Chapter%2017%20-%20Chlorhexidine.pdf
85. A Case of Anaphylaxis to Chlorhexidine during Digital Rectal Examination - PubMed Central, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2526523/
86. Chlorhexidine | Anaphylaxis UK, accessed July 21, 2025, https://www.anaphylaxis.org.uk/wp-content/uploads/2022/06/Chlorhexidine-Factsheet.pdf?x15827
87. FDA: Some antiseptics may cause serious allergic reactions - AAP Publications, accessed July 21, 2025, https://publications.aap.org/aapnews/news/9236/FDA-Some-antiseptics-may-cause-serious-allergic
88. Using chlorhexidine with other medicines and herbal supplements - NHS, accessed July 21, 2025, https://www.nhs.uk/medicines/chlorhexidine/using-chlorhexidine-with-other-medicines-and-herbal-supplements/
89. Chlorhexidine Gluconate: Side Effects, Uses, Dosage, Interactions, Warnings - RxList, accessed July 21, 2025, https://www.rxlist.com/chlorhexidine_gluconate/generic-drug.htm
90. Chlorhexidine topical Interactions - Drugs.com, accessed July 21, 2025, https://www.drugs.com/drug-interactions/chlorhexidine-topical.html
91. Chlorhexidine Gluconate (Oral - Memorial Sloan Kettering Cancer Center, accessed July 21, 2025, https://www.mskcc.org/cancer-care/patient-education/medications/adult/chlorhexidine-gluconate-oral
92. Still Not Sterile: Chlorhexidine gluconate treatment does not completely reduce skin microbial bioburden and promotes pathogen overabundance in patients undergoing elective surgeries | bioRxiv, accessed July 21, 2025, https://www.biorxiv.org/content/10.1101/2024.07.20.602341v1.full-text
93. Hospital environments harbor chlorhexidine tolerant bacteria potentially linked to chlorhexidine persistence in the environment | medRxiv, accessed July 21, 2025, https://www.medrxiv.org/content/10.1101/2024.10.07.24315058v1.full-text
94. Synthesis, Drug Release, and Antibacterial Properties of Novel Dendritic CHX-SrCl2 and CHX-ZnCl2 Particles - PMC - PubMed Central, accessed July 21, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8625704/
95. Drug Approval Package: Chlorhexidine Gluconate NDA #021669 - accessdata.fda.gov, accessed July 21, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/21669s000TOC.cfm
96. FDA warns of reaction to skin antiseptic products containing chlorhexidine gluconate | AHA News - American Hospital Association, accessed July 21, 2025, https://www.aha.org/news/headline/2017-02-03-fda-warns-reaction-skin-antiseptic-products-containing-chlorhexidine